Khoso Baluch

Insider Reports History

Location
1430 Us Highway 206, Suite 200, Bedminster, NJ
Signature
/s/ Khoso Baluch by John J. Wolfel, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Khoso Baluch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Longeveron Inc. Director Class A Common Stock 52.5K $43.6K $0.83 Aug 11, 2025 Direct
Processa Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 300K Oct 1, 2025 Direct
Processa Pharmaceuticals, Inc. Director Restricted Stock 207K Jul 24, 2025 Direct
Processa Pharmaceuticals, Inc. Director Restricted Stock Units 100K Oct 1, 2025 Direct
Longeveron Inc. Director Warrant (right to buy) 29.4K Aug 11, 2025 Direct

Insider Reports Filed by Khoso Baluch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCSA Processa Pharmaceuticals, Inc. Oct 1, 2025 2 $0 4 Oct 3, 2025 Director
LGVN Longeveron Inc. Aug 11, 2025 2 $0 4 Aug 13, 2025 Director
PCSA Processa Pharmaceuticals, Inc. Jul 24, 2025 1 $0 4/A Sep 18, 2025 Director
LGVN Longeveron Inc. Jul 15, 2025 1 $0 4 Jul 17, 2025 Director
LGVN Longeveron Inc. Dec 2, 2024 1 -$2.59K 4 Dec 4, 2024 Director
PCSA Processa Pharmaceuticals, Inc. Sep 3, 2024 1 $0 4 Sep 18, 2024 Director
LGVN Longeveron Inc. Aug 15, 2024 1 $0 4 Aug 19, 2024 Director
LGVN Longeveron Inc. Jun 9, 2024 1 -$133 4 Jun 11, 2024 Director
LGVN Longeveron Inc. Dec 28, 2023 2 $14.3K 4 Jan 2, 2024 Director
LGVN Longeveron Inc. Dec 21, 2023 1 $0 4 Dec 26, 2023 Director
PCSA Processa Pharmaceuticals, Inc. Jun 27, 2023 3 $0 4 Jul 24, 2023 Director
LGVN Longeveron Inc. Jun 9, 2023 1 $0 4 Jun 12, 2023 Director
LGVN Longeveron Inc. Jun 9, 2023 0 $0 3 Jun 12, 2023 Director
PCSA Processa Pharmaceuticals, Inc. Feb 9, 2023 1 $10K 4 Feb 10, 2023 Director
PCSA Processa Pharmaceuticals, Inc. Jul 12, 2022 1 $0 4 Jul 14, 2022 Director
PCSA Processa Pharmaceuticals, Inc. Jul 11, 2022 0 $0 3/A Jul 12, 2022 Director